William Schleicher, MD
Plastic and Reconstructive Surgery · Cleveland, OHNPI 1063619427
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $389 of the $634 with a category attached, or 61.3%. 6 manufacturers reported payments, led by Integra Lifesciences Corporation at 42.4% of the total. Reporting peaked in 2024 at $301 and has fallen 85.2% since, to $44 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in OH, where the typical reported total is $1,639.
Across 16 payments — averaging $39.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$269
- Smith+Nephew$198
- Sun Pharmaceutical Industries Inc.$66
- Pacira Pharmaceuticals Incorporated$63
- Bsn Medical Inc$24
- AbbVie$14
What the payments were for
- Food & beverage$38961%
- Other$24539%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 2 | $269 |
| Smith+Nephew | 5 | $198 |
| Sun Pharmaceutical Industries Inc. | 4 | $66 |
| Pacira Pharmaceuticals Incorporated | 3 | $63 |
| Bsn Medical Inc | 1 | $24 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$634 in reported general payments places this provider in the 35th percentile of 78 plastic and reconstructive surgery providers in Ohio.
See all plastic and reconstructive surgery providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 26 | $336 |
| Doxycycline Hyclate | 38 | $272 |
| Tramadol Hcl | 31 | $49 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Cleveland
- James GatherwrightCleveland$52K
- Abeer KalandarCleveland$34K
- Wei ChenCleveland$10K
- Steven BernardCleveland$9K
- Howard WangCleveland$7K
- William LeavittCleveland$7K
- Fatma TuncerCleveland$6K
- Nicholas SinclairCleveland$4K
- Corinne WeeCleveland$2K
- Nidal Al DeekCleveland$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.